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The importance and complexity associated with the totality of glycan structures, i.e. the glycome, has
garnered significant attention fromchemists andbiologists alike. However, what is lacking from this biochem-
ical picture is how cells, tissues, and organisms interpret glycan patterns and translate this information into
appropriate responses. Lectins, glycan-binding proteins, are thought to bridge this gap by decoding the gly-
come and dictating cell fate based on the underlying chemical identities and properties of the glycome. Yet,
our understanding of the in vivo ligands and function formost lectins is still incomplete. This review focuses on
recent advances in chemical tools to study the specificity and dynamics of mammalian lectins in live cells. A
picture emerges of lectin function that is highly sensitive to its organization, which in turn drastically shapes
immunity and cancer progression. We hope this review will inspire biologists to make use of these new tech-
niques and stimulate chemists to continue developing innovative approaches to probe lectin biology in vivo.Introduction
The glycome is an information-rich dataset that influences
almost every facet of molecular, cellular, and organismal biology
(Varki et al., 2008). The potential complexity of the glycome ex-
ceeds that of other biomolecules, e.g. proteins and nucleic acids
(Ohtsubo andMarth, 2006). In mammals, this molecular diversity
arises from the action of250 glycosyltransferases that catalyze
the addition of different sugar building blocks to their substrates
with various regio- and stereochemical specificities. The primary
decoders of the glycome are lectins, glycan-binding proteins
that are abundant in all domains of life (Lee and Lee, 1995;
Sharon, 2007). Lectin interactions with specific glycan structures
are responsible for protein folding and sorting, cell adhesion and
trafficking, pathogen recognition, and mammalian fertilization,
among other processes (Varki et al., 2008).
Modern genome sequencing efforts have led to prediction of
over 160 putative lectins in humans alone, a rich starting point
for new discoveries in glycobiology. However, identifying the
authentic biological ligands of each lectin remains challenging,
as does elucidation of the role of the lectin in normal and patho-
logical processes. In earlier decades, lectins were often charac-
terized based on their ability to aggregate cells: the so-called
agglutination assay (Sharon and Lis, 2004). Their ligand specific-
ities were assigned by screening available saccharides as agglu-
tination inhibitors. The results of such crude assays are still
evident in the stated specificities of commercial lectins that are
widely used as research tools. Yet, we now know that these
ligand assignments are at best incomplete and in many cases
misleading. In modern times, more accurate ligand assignments
can be made by glycan microarray screens (Rillahan and Paul-
son, 2011). The most advanced of these platforms comprise
over 600 vertebrate glycan structures (Wang et al., 2014) or
300 microbially derived structures, immobilized on slides that
can be screened using fluorophore-conjugated lectins. The re-Chemistry & Biolosults of such screens have revised our understanding of lectin
specificity and improved our appreciation of their biological roles
(Geissner et al., 2014).
Still, present-day glycan microarrays do not capture critical el-
ements of the biological situation. In nature, glycans are dis-
played on particular protein or lipid scaffolds, which in many
cases contribute to lectin specificity (Pouyani and Seed, 1995;
Sako et al., 1995; Wilkins et al., 1995). In addition, the spatial
arrangement and density of glycan ligands, in concert with the
multivalency and distribution of cognate lectins, factor into the
biological response these interactions mediate. These facets of
lectin biology are difficult to emulate in artificial experimental
platforms and therefore have been difficult to study.
As more lectins are discovered and characterized, it has also
become clear that individual lectin families have their own unique
properties and peculiarities. Manymembrane-associated lectins
exist in different oligomeric states that have been proposed to
regulate ligand binding, signaling, and organization of higher or-
der complexes (Brewer et al., 2002). Some lectins interact with
cognate ligands on opposing cells in a manner dependent on
force (Marshall et al., 2003), while others can interact with ligands
in the same cell membrane (Han et al., 2005). Further, certain lec-
tins have been found to possess activating or inhibiting motifs,
essential elements for proper signal transduction. Since most
lectins are thought to lack regulatory domains or allosteric
control, lectin trafficking and subcellular localization, and their
respective dynamics, control how and when lectins exert their
function in many cases (Gabius et al., 2011).
The complexities inherent to lectin biology have motivated the
development of new experimental approaches, many of which
are rooted in chemistry. In this review, the focus is on recent
contributions aimed at identifying the endogenous biological
ligands of a lectin or on probing the dynamic aspects of lectin
biology using live cells. We concentrate here on three chemicalgy 22, August 20, 2015 ª2015 Elsevier Ltd All rights reserved 983
Figure 1. Recent Chemical Methods Have
Begun to Elucidate the Binding Partners
and Dynamic Behavior of Mammalian
Lectins In Vivo
(A) Metabolic labeling with crosslinking sugars can
report on the in situ interactions between lectins
and glycans. The black arrow indicates a covalent
crosslink that has captured an endogenous lectin
in vivo.
(B) Glycoprotein mimics are synthetic, multimeric
structures designed to emulate the spatial distri-
bution of glycan epitopes on natural glyco-
conjugate ligands.
(C) New tagging and imaging technologies for
monitoring lectin trafficking and organization
in vivo.
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covery of endogenous ligands, (2) use of synthetic glycoconju-
gate mimics to study lectin function, and (3) imaging strategies
to probe lectin organization and dynamics (Figure 1). Although
this is by no means an exhaustive list of techniques for interro-
gating lectin binding and dynamics, these tools have trans-
formed our understanding of lectin-glycan interactions in vivo
and will continue to reveal unexpected features of mammalian
lectins in the future.
Metabolic Labeling with Crosslinking Sugars
Amajor goal in lectin research is the identification of endogenous
biological ligands: the truebindingpartners, engagementofwhich
triggers a biological response. Some lectins interact with glycan
structures that can be found on a variety of underlying scaffolds,
such as N- and O-glycoproteins as well as glycolipids. Figuring
outwhich subset of these are the predominant ligands in a biolog-
ical setting is adaunting task.Anemergingapproach to identifying
native lectin ligands is to trap them in a covalent complex. The
challenge of performing such an experiment in the context of
live cells lies in arming potential glycoconjugate ligands with a
crosslinkable functional group.Thishasbeenaccomplishedusing
the technique of metabolic glycan engineering.
First demonstrated by Reutter and coworkers (Kayser et al.,
1992a, 1992b), metabolic glycan engineering relies on the
native cellular biomachinery to incorporate non-natural mono-
saccharides into native glycoconjugates. In their classic work,
N-acetylmannosamine (ManNAc) analogs bearing unnatural
N-acyl chains were shown to be converted to the corresponding
sialic acids, which were incorporated into glycoproteins in
cultured cells and laboratory animals (Keppler et al., 2001).
We and others expanded upon this idea using chemically func-
tionalized ManNAc analogs bearing bioorthogonal ketone, thiol,
azide, and alkyne groups (Bussink et al., 2007; Hsu et al., 2007;
Mahal et al., 1997; Sampathkumar et al., 2006; Saxon and Ber-
tozzi, 2000). Similarly, these bioorthogonal functional groups
have been incorporated into glycans containing N-acetylgalac-
tosamine (GalNAc) (Hang et al., 2003), N-acetylglucosamine
(GlcNAc) (Vocadlo et al., 2003; Zaro et al., 2011), fucose
(Dehnert et al., 2011; Hsu et al., 2007; Rabuka et al., 2006; Al-
Shareffi et al., 2013), and xylose residues (Beahm et al., 2014)
in vertebrate systems. Incorporation of a bioorthogonal group
into cellular glycans enabled subsequent reaction with fluores-984 Chemistry & Biology 22, August 20, 2015 ª2015 Elsevier Ltd Allcent probes for imaging or affinity reagents for enrichment
and proteomic analyses. These pioneering efforts provided ev-
idence that similar glycan structures on a variety of different
protein and lipid scaffolds could be targeted using a meta-
bolism-based approach. Recently, a number of reports have
detailed the combination of metabolic labeling and Fo¨rster reso-
nance energy transfer (FRET) for imaging proteins bearing
particular glycan structures (Belardi et al., 2013; Haga et al.,
2012; Lin et al., 2014).
Paulson and coworkers were the first to adapt metabolic
glycan engineering for the purpose of capturing native lectin-
ligand complexes. Their focus was Siglec-2, or CD22, a member
of the sialic acid-binding immunoglobin-like lectin (siglec) family
known to modulate immune cell activation (Walker and Smith,
2008). CD22 comprises an extracellular sialic acid-binding
domain, a single transmembrane domain, and a cytosolic immu-
noreceptor tyrosine-based inhibitory motif that when phosphor-
ylated recruits SH2 domain-containing phosphatase 1 (Tedder
et al., 2005). Engagement of CD22 at the immune synapse in-
hibits downstream signaling associated with B cell receptor
(BCR) triggering, thereby limiting autoimmunity. On resting B
cells, however, it was hypothesized that cis interactions with
other B cell surface glycoproteins masked the lectin domain of
CD22, preventing CD22 and BCR co-localization.
To identify the cis ligands of CD22, Han et al. (2005) metabol-
ically labeled B cells with a C-9 azidoaryl sialic acid analog
(9-AAz-NeuAc). Upon UV exposure, azidoarenes form reactive
nitrenes that capture proximal proteins by C-H bond insertion.
Immunoprecipitation of CD22 from 9-AAz-NeuAc-treated and
irradiated B cells revealed a single crosslinked glycoprotein
ligand: CD22 itself. That is, CD22 appears to bind in cis to other
CD22 molecules through interaction of its lectin domain with
CD22-associated glycans. Glycoproteins that bound soluble
CD22 fusion constructs in vitro, for example CD45 and CD19,
were not crosslinked to CD22 in vivo, emphasizing the potential
specificity of this metabolism-based approach. In addition,
the crosslinked products had apparent molecular weights >
400 kDa, suggesting that CD22 forms multimers on the cell sur-
face. This last finding also reflects the unique organization of
CD22 in vivo. The cytosolic domain of CD22 has a motif that is
recognized by a component of clathrin-coated pits and therefore
may reinforce CD22 self-association and microdomain forma-
tion on resting B cells.rights reserved
Figure 2. Structures ofMetabolic Crosslinking Sugars that Generate
Nitrenes or Carbenes, Shown in Red, upon UV Exposure
These intermediates then react with lectins in vivo to form stable covalent
adducts.
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slinking strategy to identify trans ligands of CD22 on opposing
target cells (Ramya et al., 2010). During B-cell engagement, gly-
coproteins on apposing cells unmask CD22, changing its organi-
zation on the cell surface. Subsequent localization to cell-cell
synapses enriched in BCR downregulate immune signaling.
The authors generated a list of potential glycoprotein candidates
that interact during B cell-B cell contact by first incubating K20
cells, which are deficient in endogenous sialic acid production,
with 9-AAz-NeuAc. Intact cells were then treated with a soluble
CD22-Fc chimera, a surrogate for B cells, and exposed to
UV light. After lysis, crosslinked species were characterized via
various proteomicsmethods, revealing 27 potential trans ligands
of CD22, of which IgM (a component of the BCR), CD45, and
basigin were validated in cell-cell binding assays. IgM was the
most robustly crosslinked and thus subjected to further studies.
CD22 and IgM were found to redistribute and colocalize prefer-
entially to the sites of B cell-B cell contact in a lectin- and glycan-
dependent manner.
There are limitations associated with functionalizing C-9 of
sialic acid. The hydroxyl group at this position can undergo
further modifications, such as 9-O-acetylation, 9-O-lactylation
and 9-phosphorylation (Yu and Chen, 2007), which precludes
use of 9-AAz-NeuAc in situations in which elaborated versions
of sialic acid are under investigation. Kohler and coworkers
circumvented this problem by replacing the N-acetyl group of
ManNAc with an N-acyl diazirine photolabile functionality
(Tanaka and Kohler, 2008). Diazirines are known to generate car-
benes after UV illumination and can crosslink binding partners
that are in close association (MacKinnon and Taunton, 2009).
Another liability with 9-AAz-NeuAc is its low incorporation levels
in normal mammalian cell lines, while the smaller structural
perturbation associated with the diazirine group enhances
competition with endogenous sialic acids, leading to greater
levels of metabolic incorporation. Both K20 cells and wild-type
K88 cells fed the fully protected diazirine-ManNAc analog,
Ac4ManNDAz, incorporated SiaDAz into cell surfaces glycans.
Once there, SiaDAz crosslinked CD22 upon UV irradiation. ThisChemistry & Bioloresult provided further evidence that CD22 forms cis multimers
on resting B cells. Kohler and coworkers went on to show that
the chain length of N-acyl diazirines was crucial for efficient
metabolic incorporation (Bond et al., 2011). ManNDAz deriva-
tives containing two (2me), three (3me), or four (4me) methylene
groups in the N-acyl chain were synthesized and evaluated
(Figure 2). In Daudi B cells, only Ac4ManNDAz (2me) was found
to crosslink CD22, which defines the maximal structural pertur-
bation permissible by the metabolic machinery.
In less than a decade, metabolic crosslinking sugars have
unearthed surprising features of CD22 on B cells. Many glyco-
proteins are modified with an N-acetylneuraminic acid a(2,6)
galactose structure (Neu5Ac-a(2,6)-Gal), but among the plethora
of possible binding partners of the lectin CD22, only CD22 and
IgM appear to govern cis and trans interactions in vivo, respec-
tively. Kohler and coworkers have recently expanded the library
of crosslinking sugars to other monosaccharide structures (Yu
et al., 2012), and we anticipate that many of these derivatives
will be used to detect additional lectin-glycan interactions in
the future.
We envision future research toward inverting the current
placement of the crosslinking functional group. If the crosslink-
ing moiety is placed within the lectin, then, this may provide a
means to efficiently capture in vivo glycoprotein ligands, partic-
ularly in cases in which the carbohydrate specificity of a lectin is
not well understood. Incorporation of photoreactive benzophe-
nones into proteins has already been accomplished in mamma-
lian cells through unnatural amino acid mutagenesis (Hino et al.,
2005). This technology could be expanded to the recognition
domain of most lectins in vivo. Mass spectrometry (MS) will
certainly play a major role in sequencing the captured ligands af-
ter crosslinking. MS/MS has become in indispensable tool and in
many cases routine for glycoproteomics (Marin˜o et al., 2010; Pan
et al., 2011; Kailemia et al., 2014). Yet, for years, MS-based tech-
niques to profile protein glycosylation have relied on liberating
the glycan moiety from the protein or peptide backbone, which
would obscure many of the fine details of lectin ligands. New
unbiased MS methods have emerged that profile intact glyco-
peptides (Yin et al., 2013; Wu et al., 2014; Woo et al., 2015).
We imagine these approaches and new developments in MS
will eventually provide unprecedented information on the precise
glycoprotein structures involved in lectin adhesion in vivo.
Glycoprotein Mimics
Many glycoproteins, especially mucin-type O-glycoproteins, are
heavily elaborated biomolecules with multiple glycosylation
sites. The glycan structures on a single protein backbone can
vary dramatically from site to site, making analysis of lectin-
glycoprotein interactions difficult. The protein backbone is
known to modulate glycan presentation, sometimes restricting
glycan conformation and subcellular localization. Further still,
many possess weak affinity for their putative monomeric glycan
ligands (Kd values of 100 mM to 1 mM). Multivalency, the pres-
ence of numerous glycan ligands on a single scaffold, can
dramatically increase the avidity of lectins for their oligomeric
targets.
As a post-translational modification, glycosylation is not
amenable to direct genetic manipulations, and encoding a spe-
cific glycan structure along a single polypeptide backbone withgy 22, August 20, 2015 ª2015 Elsevier Ltd All rights reserved 985
Figure 3. A 30,6-Disulfated Lewis 3 Glycopolymer Promotes L-Selectin Shedding from Leukocytes by Forming Membrane Clusters
Reprinted from Gordon et al. (1998b) with permission from Elsevier.
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biomimicry to construct molecular surrogates that emulate the
essential features of glycoconjugates but differ in tunable com-
position and properties (Poupon and Nay, 2011). Three general
classes of well-defined glycoprotein mimics have been synthe-
sized and used to study mammalian lectins both in vitro and
in vivo: glycopolymers (Ladmiral et al., 2004), linear polymers
with pendant glycans; glycodendrimers (Turnbull and Stoddart,
2002), highly branched architectures with terminal glycan resi-
dues; and glycoparticles (De la Fuente and Penade´s, 2006),
organic or inorganic micro-/nanoscale materials, or liposomal
compositions that are functionalized with glycans through var-
ious surface chemistries. As opposed to the native heteroge-
neous glycoforms of proteins, these synthetic glycoconjugates
offer the ability to incorporate homogeneous glycans structures
onto a spatially defined platform. This section focuses on glyco-
polymers as mimics of glycoproteins, since these materials have
yielded profound insights into lectin biology.
The original synthesis of glycopolymers dates back to the
1970s (Schnaar and Lee, 1975). Since then, glycopolymers
have found widespread use as lectin inhibitors, for instance dur-
ing bacterial and viral infection (Sigal et al., 1996), and as tools for
describing the biophysics of multivalency in vitro (Becer, 2012;
Deniaud et al., 2011; Spain et al., 2007). In the past decade,
chemical biologists have continued to push glycopolymers into
the biological milieu (Kiessling and Grim, 2013). Free glycopoly-
mers resemble soluble, secreted glycoproteins, and as a result
of improved synthetic methodology, it is now possible to prepare
glycopolymers that mimic membrane-bound glycoproteins. One
caveat to most of these materials is that they eliminate an impor-
tant binding surface for the lectin, i.e. the protein itself. Still, with
these tools in hand, a number of questions relating to lectin
dynamics are now accessible and have been addressed for
three large families of lectins, namely C-type lectins, siglecs,
and galectins.
Selectins, calcium-dependent lectins (C-type lectins), are crit-
ical mediators of cell adhesion, especially during immune cell
homing (Rosen, 2004). The three selectins, P, L, and E, are
expressed on different cell types, platelets, leukocytes, and
endothelial cells, respectively (P-selectin is also expressed on
activated endothelium). During the inflammatory response,
leukocytes roll along endothelial cells, adhere to the vascular
substrate, and extravasate into the damaged tissue. It is the
early rolling stage that involves selectin-ligand interactions. Like-986 Chemistry & Biology 22, August 20, 2015 ª2015 Elsevier Ltd Allwise, the upregulation of L-selectin on leukocytes can lead to
enhanced leukocyte migration and inflammatory damage, and
therefore L-selectin density is tightly regulated on leukocyte
surfaces. The glycan ligands of L-selectin possess sulfated ver-
sions of the sialyl Lewis 3 epitope (sLex, Neu5Aca2-3Galb1-
4(Fuca1-3)GlcNAc).
Kiessling and coworkers were interested in how the differential
sulfation of this epitope affected L-selectin binding and leuko-
cyte rolling (Gordon et al., 1998a, 1998b; Mowery et al., 2004;
Sanders et al., 1999). They employed a type of living polymeriza-
tion, ring opening metathesis polymerization (ROMP), to pro-
duce well-defined glycopolymers with pendant sLex derivatives.
Starting from functionalized norbornenes, different glycopoly-
mers bearing unsulfated, mono- or disulfated sLex were pre-
pared. Once their relative binding was ascertained, the glycopol-
ymers were evaluated for their abilities to induce shedding of
cell-surface L-selectin, a phenomenon thought to naturally re-
gulate its inflammatory contribution. A 30,6-disulfated Lewis 3
glycopolymer caused the most significant decrease in surface
L-selectin levels after binding, whereas monovalent analogs
were inactive. The data provided evidence that clustering of
L-selectin by the multivalent ligand induced proteolysis from
the cell surface (Figure 3). Importantly, these findings suggest
a mode of therapeutic intervention wherein L-selectin shedding
is induced, and inflammatory leukocyte recruitment muted, by
synthetic glycopolymers.
To address how spacing of these glycan epitopes along
a scaffold might modulate the consequences of L-selectin
clustering, Kiick and coworkers prepared artificial glycopro-
teins based on alanine-rich recombinant polypeptides (Liu and
Kiick, 2011). Glycan conjugation to glutamic acid residues at
defined positions yielded spatially defined, a-helical glycopro-
tein mimics. Specifically, disulfated galactosyl amines were
coupled to the polypeptide backbone with O-(benzotriazol-1-
yl)-N,N,N0,N0-tetramethyluronium hexafluorophosphate (HBTU)
and arranged at two different distances, 1.7–3.5 nm and 3.5–
5.0 nm. Jurkat T cells were incubated with these glycopolypep-
tides, and the amount of L-selectin shedding was determined by
an ELISA for the protein. As anticipated, monovalent glycans and
an unstructured glycopolypeptide did not induce L-selectin
shedding. However, while the 1.7–3.5 nm construct resulted in
L-selectin cleavage, the 3.5–5.0 nm glycopolypeptide, unex-
pectedly, did not. This differential shedding activity highlights
that the dynamics of selectin organization on cell surfacesrights reserved
Figure 4. The Siglec, CD22, Exists in
Homomultimers on Resting B Cells but Is
Unmasked in the Presence of a Multivalent
Glycopolymer, BPC-NeuAc-PAA, of
Sufficient Avidity
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calmodulin release from the cytoplasmic tail of L-selectin, which
is then followed by a conformational change that enhances sus-
ceptibility to sheddase activity (Grailer et al., 2009). This work
suggests another parameter that influences signaling and shed-
ding of L-selectin: the spatial arrangement of L-selectin binding
epitopes.
Another C-type lectin, dendritic cell (DC)-specific intercellular
adhesion molecule (ICAM)-3-grabbing nonintegrin (DC-SIGN),
carries out a multitude of functions on DCs through interactions
with high mannose glycans and fucosylated Lewis-type antigens
on ICAM-3 and ICAM-2 (Svajger et al., 2010). DC-SIGN stabilizes
immunological synapses during T cell engagement and can
mediate trans-endothelial migration. The lectin was also thought
to be involved in antigen uptake and processing, a proposal
confirmed by Kiessling and coworkers using synthetic glycocon-
jugates (Prost et al., 2012). BSA, serving as a polymeric back-
bone, was decorated at its lysine residues with mannosyl or
fucosyl glycans. Fluorophore-functionalized BSA glycoconju-
gates were administered to Raji cells, a B cell line, stably trans-
fected with the gene for DC-SIGN (Raji/DC-SIGN). The Raji/DC-
SIGN cells, but not thewild-type Raji cell line, internalized all three
glycoconjugates. The glycoprotein surrogates also stimulated
JNK signaling in response to interaction with DC-SIGN. Phos-
phorylation of JNK was not seen in other studies of DC-SIGN
binding, leading to the proposal that DC-SIGN reorganization
and perhaps clustering are necessary for signaling to take place.
C-type lectin-dependent uptake may be a general feature in
antigen processing, as polyacrylamide (PAA)-GalNAc glycopoly-
mers were found by Irimura and coworkers to be readily internal-
ized by DCs through macrophage galactose-type C-type lectin 2
(Denda-Nagai et al., 2010).
As discussed above, CD22 belongs to the siglec family of lec-
tins. An important siglec on B cells, CD22 downregulates im-
mune cell activation via recruitment of SHP-1 phosphatase to
the site of receptor signaling.Cis a2,6-linked sialic acid-CD22 in-
teractions were shown to mask CD22 on resting B cells. But one
question remained: what are the properties of trans ligands that
promote escape of CD22 from cis ligand-dependent multimers?
Paulson and coworkers examined this question using a series of
sialoside glycopolymers (Collins et al., 2006). Biotinylated PAAChemistry & Biology 22, August 20, 2015polymers of either 30 or 1,000 kDa were
used as scaffolds for the attachment of
sialosides, including NeuAc and its C-9-
biphenyl derivative (BPC-NeuAc) as well
as the native N-glycolylneuraminic acid
(NeuGc) and its C-9-biphenyl derivative
(BPA-NeuGc). Aromatic groups at the
C-9 position of sialic acid had been previ-
ously shown to increase affinity toward
CD22 (Zaccai et al., 2003). The prepared
glycopolymers were added to eitherBJAB or Daudi B cells, and flow cytometry was used to detect
glycopolymer binding. Only the 1,000-kDa BPC-NeuAc-PAA
and BPA-NeuGc-PAA polymers adhered to the B cell surface.
The native sialoside polymers, NeuAc-PAA and NeuGc-PAA,
as well as the 30-kDa glycopolymers did not exhibit cell-surface
binding. A simple interpretation of these findings is that CD22
exists in a dynamic equilibrium on the surface of B cells. If pre-
sented with exogenous ligands of sufficient avidity, the CD22
binding equilibrium favors unmasking from cis ligands, whereas
weak exogenous ligands cannot compete with self-association
in cell-surface multimers (Figure 4). Only in the case when
CD22 is presented with highly multivalent glycopolymers,
1,000 kDa, containing high-affinity glycan derivatives, i.e. BPC-
NeuAc and BPA-NeuGc, does unmasking occur. The authors
also provide evidence that the CD22-bound PAA glycopolymers
undergo clathrin-mediated endocytosis into early endosomes
that is dynamin dependent (Tateno et al., 2007).
In an elegant follow-up report, Kiessling and coworkers used
glycopolymers to study the consequences of engaging both
CD22 and BCR on B cell activation (Courtney et al., 2009). A
well-defined, ROMP-derived N-hydroxysuccinimidyl ester poly-
mer was elaborated either with BCR ligands (2,4-dinitrophenyl,
DNP), CD22 ligands (CD22L), or both (DNP/CD22L). Polymers
with BCR and CD22 ligands on the same polymer backbone
induced clustering of the two proteins (Figure 5). As well, cells
treated with DNP polymer displayed an increase in cytosolic cal-
cium concentration. The DNP/CD22L copolymer, on the other
hand, had no such effect. No calcium influx was observed for
the copolymer, and downstream BCR signaling targets, such
as Syk and PLC g2, had reduced phosphorylation compared
with DNP polymer-treated cells. Incubation with the DNP poly-
mer or the DNP/CD22L copolymer produced similar early
signaling patterns in B cells; both Lyn and CD22 became phos-
phorylated upon polymer engagement. The authors proposed
that after BCR attachment, the increase in local concentration
of polymer on the membrane facilitates CD22 trans association.
Collectively, the data also indicate that co-clustering of BCR and
CD22 on the cell surface elicits early B cell activation but atten-
uates downstream signaling effectors. The copolymer data
strongly suggest that CD22 dynamics can be modulated by
the sialylation state of an antigen, which could be an innateª2015 Elsevier Ltd All rights reserved 987
Figure 5. A Soluble Copolymer Engages Both BCR and CD22
Simultaneously
Glycopolymer binding reorganizes CD22 to sites of BCR activation and blocks
downstream signaling. The CD22 ligands are composed of sialic acid resi-
dues, suggesting that sialylation may be a molecular form of self in mammals.
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aid of homogeneous glycoprotein mimics.
To further explore the influence of B cell siglecs on immune
tolerance, PAA copolymers were synthesized bearing both a
BCR ligand (nitrophenol [NP]) and either a native CD22 ligand
(NeuGc) or a high-affinity unnatural CD22 ligand (9-biphenyl
NeuGc, bNeuGc) (Duong et al., 2010). Mice immunized with
NP-PAA produced a strong antibody response as expected. In
contrast, mice immunized either with the NP-PAA-NeuGc copol-
ymer or the NP-PAA-bNeuGc copolymer failed to elicit high anti-
NP antibody titers. These results agree with the above findings
that B cell signaling is attenuated by co-engagement of CD22
and BCR. To test whether glycopolymer antigen challenge
shaped the subsequent immune response of the organism,
mice that had been treated with sialylated antigen were then
immunized with unsialylated NP-PAA. Drastically reduced anti-
body titers were observed, a hallmark of antibody suppression
and immune tolerance. Tolerance induction was associated
with suboptimal B cell proliferation and arrest of plasma B cell
differentiation. In addition, long-term tolerance was correlated
with the strength of siglec binding, as NP-PAA-bNeuGc
copolymers produced the highest immune tolerance. CD22
can thus confer a graded output when presented with different
glycosylated antigens. This work points to an underexplored
area of immunotherapy, namely targeting siglecs, and the poten-
tial of harnessing single glycoconjugates simultaneously pre-
senting BCR and inhibitory siglec ligands as immunoregulators.
Yet, what mechanisms are responsible for producing a spec-
trum of B cell activation? Kiessling and coworkers explored how
the dynamics of lectin trafficking relate to B cell signaling (Court-
ney et al., 2014). B cells were incubated with DNP polymer or
DNP/CD22L copolymers, and BCR endocytosis was tracked
by fluorescence microscopy. The cell-surface half-life of BCR
was significantly longer for cells treated with DNP polymer
compared with cells treated with DNP/CD22L copolymer. Co-
clustering of BCR andCD22 on B cell surfaces triggered endocy-988 Chemistry & Biology 22, August 20, 2015 ª2015 Elsevier Ltd Alltosis, which resulted in accumulation of BCR in early endo-
somes. Glycosylation-dependent internalization was mediated
by dynamin and initiated by early phosphorylation of BCR and
CD22 through Lyn. This mechanism of BCR regulation provides
a means for B cells to tailor their BCR levels based on the sialy-
lation state of an antigen and, in turn, increase the threshold of B
cell activation to subsequent antigen encounter.
Immune cells other than B cells also possess unique reper-
toires of siglecs. One example is natural killer (NK) cells, which
act as early responders to pathogens and cancerous cells, lead-
ing to cell death and clearance (Kumar and McNerney, 2005).
Human NK cells prominently express Siglec-7 and to a lesser
extent Siglec-9 (Crocker et al., 2007). Early work by Nicoll et al.
(2003) used soluble glycopolymers to establish that, similar to
CD22, Siglec-7 is masked on NK cells by the disialylated gangli-
oside GD3. The similar domain organization of Siglecs-7 and -9
to CD22 suggests roles in downregulating NK cell activation, but
the precise roles of these siglecs in NK cell biology was unclear.
As an integral part of the innate immune response, NK cells act to
contain the growth and metastasis of tumor cells. Aggressive
cancers, however, are able to evade NK cells through the release
of activating receptors or expression of inhibitory motifs. There
is a body of literature associating hypersialylation of cells with
malignancy, prompting speculation that this glycomic signature
might protect cancers cells from immune surveillance by down-
regulating NK cells.
To test this hypothesis, our laboratory designed sialylated gly-
copolymers functionalized with a lipid at one terminus, enabling
insertion into live cell membranes (Rabuka et al., 2008). Hudak
et al. (2014) employed these reagents to modify cancer cells
and thereby test the effects of engineered hypersialylation on
susceptibility to NK cell killing. Jurkat cells, a hyposialylated
cell line that is known to be susceptible to NK cell killing, were
decorated with polymers and then incubated with either purified
NK cells or peripheral blood mononuclear cells. NK cytotoxicity
of Jurkat cells was strongly inhibited by sialic acid-containing
glycopolymers but not polymers lacking the terminal sugar or
polymers possessing similar charge, e.g. acetic acid, or polarity,
e.g. glycerol. Function-blocking antibodies against Siglec-7, but
not Siglec-9, abolished the protection afforded by sialic acid
polymers. Fluorescence microscopy revealed that Siglec-7 on
NK cells had reorganized to concentrate at the synapse with
sialopolymer-coated Jurkat cells. A role for immune cell siglecs
in sialic acid-dependent cancer immune surveillance was later
confirmed in mouse models (La¨ubli et al., 2014) and implicated
from human clinical samples (Jandus et al., 2014).
Galectins, another family of carbohydrate binding proteins,
differ considerably in structure from selectins and siglecs (Di
Lella et al., 2011). These proteins are soluble, and whereas
siglecs and selectins bind sialylated structures, galectins
recognize galactose- and N-acetyllactosamine-based motifs.
Moreover, many galectins oligomerize noncovalently in the pres-
ence of ligand, whereas others possess two carbohydrate
recognition domains in a single polypeptide, illustrating two
distinct mechanisms for achieving multivalency. Stemming
from their oligomeric nature, it was proposed that galectins
form a lattice-like structure with glycoprotein ligands on cell
surfaces (Rabinovich et al., 2007). Dennis and coworkers found
that limiting the number of LacNAc residues on cell-surfacerights reserved
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growth factor receptors, indicating that galectin lattices may
extend the cell-surface residence time of certain glycoproteins
(Partridge et al., 2004).
Direct experimental validation of galectin-glycoprotein lattices
had eluded researchers. Without a means of detection, physical
parameters, such as size and lifetime, were largely undefined for
galectin-mediated aggregation. Our laboratory leveraged mem-
brane-anchored glycopolymers and fluorescence spectroscopy
to verify the existence of galectin lattices (Belardi et al., 2012).
Reversible addition-fragmentation chain transfer (RAFT) poly-
merization, another type of living polymerization, offers the op-
portunity to individually manipulate both ends of a polymer chain
while also affording predictable degree of polymerization (Ked-
die, 2014; Lowe andMcCormick, 2007). Lactosyl and cellobiosyl
(negative control) acrylamide monomers were therefore sub-
jected to RAFT polymerization conditions in the presence of a
lipid-functionalized chain transfer agent. Subsequent end group
modification with a fluorophore yielded glycopolymers contain-
ing either a single FRET donor or acceptor dye. After embedding
donor and acceptor glycopolymers (1:1) into live cell mem-
branes, a decrease in fluorescence lifetime, which was indicative
of FRET, of the donor-functionalized lactosyl polymer was
observed in the presence of galectin-1. Moreover, the diffusion
time, a parameter measured by fluorescence correlation spec-
troscopy and related to clustering, for the lactosyl glycopolymer
increased only in the presence of galectin-1. By examining the
data in real time, it appears that galectin-1 mediates the dynamic
crosslinking of membrane glycoprotein mimics on the minutes
timescale and results in extended galectin networks, which are
themselves stable for tens of minutes.
Now considered invaluable tools in the chemical biologist’s
toolkit, glycoprotein mimics have been used in vivo to under-
stand the flow of information from a glycosylated biomolecule
to a lectin and the resulting cellular decision making that is
altered by carbohydrate binding. What has emerged is a picture
of lectins with functions that are highly dependent on changes in
organization that occur upon ligand binding. After glycoprotein
mimic association, lectins redistribute, form signaling clusters,
and process signals, all of which are regulated by the nature of
the glycan partners themselves. Glycoprotein mimics have
been instrumental in defining the parameters that affect lectin-
mediated signaling and membrane organization both in cell cul-
ture and in organismal studies. Present mimics, however, lack
the signaling domains associated with many glycoprotein li-
gands. In the future, it would be interesting to combine mucin-
type polymeric structures with functional domains through
semi-synthesis. Using this approach, questions regarding the
feedback between lectin dynamics and glycoprotein function
can start to be assessed.
Site-Selective Tagging and Imaging Technologies
Some problems in lectin biology require direct observation of the
lectins themselves, with fast temporal and high spatial resolu-
tion. Chemical tools, both reagents and instrumentation, are
becoming ever more important for meeting these challenges.
For example, biologists have long debated how DC-SIGN effi-
ciently recognizes glycan epitopes and captures large viral
particles and pathogens. Given the dimensions of viral particlesChemistry & Biolo(80–100 nm), researchers were interested in whether DC-SIGN
formed small clusters on the surface of immature DCs. To
examine the organization of DC-SIGN below optical resolution
(200 nm), blink microscopy, a super-resolution method, was
creatively applied by Jacobson and coworkers (Itano et al.,
2012). Blink microscopy relies on driving most fluorophores in
a densely labeled sample into a dark state through a combination
of redox reagents, leaving a few dyes fluorescing for short on
times (milliseconds). DC-SIGNwas imaged and found to reside
in nanodomains with a diameter of 76 nm. By analyzing the
number of blink localizations per cluster, the occupancy was
calculated to be 12 molecules, or three tetramers of DC-
SIGN, indicating that the cluster was sparsely occupied. This
finding was consistent with the ability of lipid molecules to easily
diffuse through DC-SIGN membrane domains. The multivalency
associated with DC-SIGN and its limited density in clusters sug-
gests an effective, yet flexible mechanism to ensure entry of
weakly binding, large antigens, e.g. HIV.
For years, another important question in lectin biology,
namely how leukocyte attachment mediated by L-selection in-
teractions is enhanced under flow, was particularly vexing.
This finding was partly rationalized by changes in cell-surface
area or number of adhesions under shear force. But to examine
L-selection dynamics under force in detail, Yago et al. (2004) im-
mobilized the L-selectin ligand, P-selectin glycoprotein ligand-1
(PSGL-1), on a substrate and measured biophysical parameters
that govern adhesion under flow with fast microscopy detectors
(250–500 frames per second). The authors monitored off rates
(koff), among other parameters, for the L-selectin-PSGL-1 inter-
action in neutrophils under various tether forces. They observed
decreases in koff as shear force was increased. This behavior is
known as a catch bond, in which bond lifetime increases under
force. In this case, instrumentation and chemical modification
were pivotal for defining the catch-bond behavior of L-selectin.
This work also supports the notion that lectin dynamics, e.g.
force-induced conformation changes, are important for biolog-
ical phenomena, like leukocyte rolling and extravasation.
Galectin-3 (Gal-3) is the onlymember of the galectin family that
belongs to the chimera subtype. This protein has been reported
to oligomerize in vitro upon binding glycan ligands, forming
multimers in solution (Ahmad et al., 2004; Lepur et al., 2012). Nie-
minen et al. (2006) were interested in observing Gal-3 oligomer-
ization using FRET in the context of neutrophil-endothelial cell
interfaces. Yet, large fluorescent protein fusions (25 kDa)
were problematic for Gal-3 since both the N and C terminus
were considered indispensable for assembly and glycan bind-
ing, respectively. To address this, a small donor or acceptor flu-
orophore, Alexa Fluor 488- or Alexa Fluor 555-cadaverine, was
conjugated to the C terminus of Gal-3 in a site-specific manner
by the enzyme, transglutaminase. Taking advantage of Gal-3
outfitted with either a donor or acceptor dye, robust FRET sig-
nals were observed in unprimed neutrophils alone as well as in
the context of neutrophil-endothelial cell adhesions. On the other
hand, Gal-3 monomers modified non-specifically at lysine resi-
dues showed limited FRET. These results suggest that Gal-3 is
oligomerized within the glycocalyx on cell surfaces. The study
also emphasizes the unmet need and demand for developing
methods capable of site-selectively modifying lectins without
perturbing activity or quaternary lectin structure. For instance,gy 22, August 20, 2015 ª2015 Elsevier Ltd All rights reserved 989
Figure 6. Fluorescent AminoAcids that HaveBeen Incorporated into
Maltose-Binding Protein and a Sialic Acid-Binding Protein
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can be modified by amyriad of benzylguanine derivatives, open-
ing the door for a range of markers useful for observing lectin dy-
namics/organization (Kupper et al., 2013).
Fluorescent amino acids are beneficial since they are small in
size and can be placed at many points throughout the protein
backbone. Fluorescence is extremely sensitive to the local envi-
ronment and has been used extensively to detect binding events
in vivo. Based on these advantages, Hohsaka and coworkers
recently pioneered the incorporation of fluorescent amino acids
into lectins (Iijima and Hohsaka, 2009; Ito and Hohsaka, 2013).
Unnatural BODIPY fluorescent amino acids were efficiently
installed in maltose-binding protein as well as in a sialic acid-
binding protein (Figure 6). In both examples, placement of the
fluorophore near the glycan-binding site created a fluorogenic
lectin, i.e. fluorescence of the amino acid is quenched by a
nearby tryptophan residue in the absence of ligand, but when
maltose or sialyllactose was administered fluorescence turns
‘‘on.’’ These examples are encouraging since they suggest that
fluorescent amino acids may be well suited to visualize lectin
binding events in vivo, obfuscating addition of large protein fu-
sions or peptide tags to the sequence of a lectin. They also illus-
trate a path to differentiate between lectins that are engagedwith
their glycoprotein ligands and the free protein.
Chemical tools have revolutionized the way molecules are
imaged and tracked inside complex biological milieu. Many of
these techniques are just now being applied to lectins. Lectins
assemble, disassemble, form crosslinked bridges between gly-
coproteins and adjacent cells, and generally act in complex, mul-
timeric forms. Non-traditional methods are needed to observe
the debated details of these processes in vivo. Recently, new
hardware and chemical reagents have revealed, for instance,
the nature of lectin binding under force and the spatial organiza-
tion of lectin domains in membranes. We believe that by
leveraging newmethods in protein modification and better imag-
ing hardware/techniques, our present understanding of lectin
dynamics and binding behavior will give way to a more refined
description. As well, we hope that in the future, researchers will
take advantage of single molecule techniques, such as single
particle tracking, coupled with site-specific fluorophore-lectin990 Chemistry & Biology 22, August 20, 2015 ª2015 Elsevier Ltd Allconjugates to resolve lectin dynamics in different subcellular
compartments, an unexplored frontier.
Conclusion
Chemists have transformed the field of glycobiology by contrib-
uting a number of methods to interrogate mammalian lectin dy-
namics in vivo. These tools have come in a variety of molecular
forms, ranging from small molecule metabolites to large macro-
molecular agents. Crosslinking sugars have revealed extraordi-
nary features of CD22 that were wholly inaccessible using typical
molecular biology techniques. The fact that CD22 is segregated
into homomultimers in resting B cells has shed light on the in vivo
consequences of lectin reorganization for tuning immune cell
activation. Glycoprotein mimics have, for instance, clarified a
novel glycan-based mechanism of NK cytotoxicity evasion by
cancer cells. Escaping immunosurveillance was, not surpris-
ingly, predicated on glycan-siglec interactions. New imaging
methods, such as super-resolution microscopy, have settled
long-standing questions concerning DC-SIGN membrane do-
mains. By precisely locating individual DC-SIGN molecules,
DC-SIGN clusters were found to be composed of only 12 mole-
cules, which explains their ability to efficiently mobilize and cap-
ture viral particles. However, in vivo specificity is still undefined
for most lectins and only recently have researchers begun to
appreciate that assembly and subcellular dynamics of lectins
profoundly dictate function and cell behavior (Croci et al.,
2014). We are in desperate need of techniques to probe the
glycoprotein ligands of lectins in full detail, i.e. sequencing the
intact glycoconjugate, and methods that define the assembly
state and trafficking history of lectins are severely limited. We
believe that chemical tools will be indispensable for elucidating
how lectins interpret glycomic changes in the future. Our hope
is that this review will stimulate further interest and work in this
new, exciting area at the interface of chemistry and biology.
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